XOM Stock Recent News

Shares of ExxonMobil (XOM -2.54%) were up as much as 2% earlier on Monday, before plunging to a 3.1% decline and then recovering slightly to a 2.5% decline to end the trading day.

XOM's aggressive project ramp-up, strong balance sheet and higher shareholder returns set it apart from E, which is witnessing slower growth.

Exxon (XOM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Shares in oil majors rose, but they weren't matching the sort of eye-popping gains investors might have expected after the U.S. bombed three key nuclear sites in Iran.

Exxon's headline numbers are nothing special lately, but I see credible upside thanks to Guyana and the Pioneer deal. Legal and policy risks are real, but the market already prices in a lot of pessimism. Compared to Shell and Chevron, Exxon's mix of returns and future growth stands out for me.

Key Points in This Article: Dividend stocks offer reliable income and growth potential, leveraging compounding to build long-term wealth while cushioning against market volatility in an uncertain economy. Quality dividend payers with strong cash flows and sustainable payout ratios outperform non-payers, historically delivering 9.2% annualized returns with lower risk. Amid inflation and potential bear markets, these stocks provide a steady cash flow hedge, ideal for investors seeking stability and compounding returns. Sit back and let dividends do the heavy lifting for a simple, steady path to serious wealth creation over time. Grab a free copy of “2 Legendary High-Yield Dividend Stocks” now. Dividend Stocks: Your Wealth-Building Shield for July With economic clouds gathering from tariff uncertainties and economic doubts amid Federal Reserve interest rate policy, dividend stocks shine as a beacon for investors craving stability and growth. These companies, known for sharing

Dividend stocks can play many roles in an investor's portfolio. Income generation is paramount.

Now is a great time to be an income and value investor, particularly in the energy and pharmaceutical spaces. I highlight 2 undervalued names that provide well-covered dividends with a strong growth outlook. The market seems to be overly rotated on near-term headwinds while ignoring the long-term growth drivers, resulting in a dislocation between price and value.

Oil prices surge 11% as Iran-Israel conflict escalates. Traders shift into Exxon, Chevron, and XLE for exposure to geopolitical risk premiums.

XOM and CVX expand in Brazil with new offshore blocks, sparking environmental backlash over Amazon rainforest proximity.